imatinib mesylate has been researched along with Coxsackie Virus Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergelson, JM; Coyne, CB; Patel, KP | 1 |
| Berndt, A; Böhmer, FD; Borsi, L; Buchdunger, E; Grün, K; Janik, T; Kiehntopf, M; Kosmehl, H; Leipner, C; Müller, A; Uecker, A | 1 |
2 other study(ies) available for imatinib mesylate and Coxsackie Virus Infections
| Article | Year |
|---|---|
Dynamin- and lipid raft-dependent entry of decay-accelerating factor (DAF)-binding and non-DAF-binding coxsackieviruses into nonpolarized cells.
Topics: Animals; Benzamides; Caco-2 Cells; Caveolins; CD55 Antigens; Coxsackievirus Infections; Dynamins; Enterovirus B, Human; Filipin; HeLa Cells; Humans; Imatinib Mesylate; Membrane Microdomains; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptors, Virus; Virus Internalization | 2009 |
Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis.
Topics: Animals; Benzamides; Coxsackievirus Infections; Disease Models, Animal; Enterovirus B, Human; Fibrosis; Heart; Imatinib Mesylate; Lymphokines; Male; Mice; Mice, Knockout; Myocarditis; Myocardium; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Signal Transduction | 2008 |